dc.contributor.author | Hingtgen, Shawn | |
dc.contributor.author | Kasmieh, Randa | |
dc.contributor.author | Elbayly, Elizabeth | |
dc.contributor.author | Nesterenko, Irina | |
dc.contributor.author | Figueiredo, Jose-Luiz | |
dc.contributor.author | Dash, Rupesh | |
dc.contributor.author | Sarkar, Devanand | |
dc.contributor.author | Hall, David | |
dc.contributor.author | Kozakov, Dima | |
dc.contributor.author | Vajda, Sandor | |
dc.contributor.author | Fisher, Paul B. | |
dc.contributor.author | Shah, Khalid A. | |
dc.date.accessioned | 2013-03-21T20:42:51Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Hingtgen, Shawn, Randa Kasmieh, Elizabeth Elbayly, Irina Nesterenko, Jose-Luiz Figueiredo, Rupesh Dash, Devanand Sarkar, David Hall, Dima Kozakov, Sandor Vajda, Paul B. Fisher, and Khalid Shah. 2012. A first-generation multi-functional cytokine for simultaneous optical tracking and tumor therapy. PLoS ONE 7(7): e40234. | en_US |
dc.identifier.issn | 1932-6203 | en_US |
dc.identifier.uri | http://nrs.harvard.edu/urn-3:HUL.InstRepos:10456185 | |
dc.description.abstract | Creating new molecules that simultaneously enhance tumor cell killing and permit diagnostic tracking is vital to overcoming the limitations rendering current therapeutic regimens for terminal cancers ineffective. Accordingly, we investigated the efficacy of an innovative new multi-functional targeted anti-cancer molecule, SM7L, using models of the lethal brain tumor Glioblastoma multiforme (GBM). Designed using predictive computer modeling, SM7L incorporates the therapeutic activity of the promising anti-tumor cytokine MDA-7/IL-24, an enhanced secretory domain, and diagnostic domain for non-invasive tracking. In vitro assays revealed the diagnostic domain of SM7L produced robust photon emission, while the therapeutic domain showed marked anti-tumor efficacy and significant modulation of p38MAPK and ERK pathways. In vivo, the unique multi-functional nature of SM7L allowed simultaneous real-time monitoring of both SM7L delivery and anti-tumor efficacy. Utilizing engineered stem cells as novel delivery vehicles for SM7L therapy (SC-SM7L), we demonstrate that SC-SM7L significantly improved pharmacokinetics and attenuated progression of established peripheral and intracranial human GBM xenografts. Furthermore, SC-SM7L anti-tumor efficacy was augmented in vitro and in vivo by concurrent activation of caspase-mediated apoptosis induced by adjuvant SC-mediated S-TRAIL delivery. Collectively, these studies define a promising new approach to treating highly aggressive cancers, including GBM, using the optimized therapeutic molecule SM7L. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Public Library of Science | en_US |
dc.relation.isversionof | doi:10.1371/journal.pone.0040234 | en_US |
dc.relation.hasversion | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394792/pdf/ | en_US |
dash.license | LAA | |
dc.subject | Biology | en_US |
dc.subject | Neuroscience | en_US |
dc.subject | Developmental Neuroscience | en_US |
dc.subject | Neural Stem Cells | en_US |
dc.subject | Neuroimaging | en_US |
dc.subject | Medicine | en_US |
dc.subject | Clinical Research Design | en_US |
dc.subject | Animal Models of Disease | en_US |
dc.subject | Drugs and Devices | en_US |
dc.subject | Drug Research and Development | en_US |
dc.subject | Drug Discovery | en_US |
dc.subject | Pharmacokinetics | en_US |
dc.subject | Drug Distribution | en_US |
dc.subject | Pharmacodynamics | en_US |
dc.subject | Oncology | en_US |
dc.subject | Cancer Treatment | en_US |
dc.subject | Cytokine Therapy | en_US |
dc.subject | Gene Therapy | en_US |
dc.subject | Cancer Prevention | en_US |
dc.title | A First-Generation Multi-Functional Cytokine for Simultaneous Optical Tracking and Tumor Therapy | en_US |
dc.type | Journal Article | en_US |
dc.description.version | Version of Record | en_US |
dc.relation.journal | PLoS ONE | en_US |
dash.depositing.author | Shah, Khalid A. | |
dc.date.available | 2013-03-21T20:42:51Z | |
dc.identifier.doi | 10.1371/journal.pone.0040234 | * |
dash.contributor.affiliated | Shah, Khalid | |